Stock listing
Tarsus Pharmaceuticals, Inc.
Selected listing: TARS · NASDAQ · USD · US
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), Health Technology. Latest release Sep 29, 2026: Tarsus Plans to Present 11 Abstracts Highlighting New Insights…
- Ticker
- NASDAQ:TARS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. is a publicly traded company on the American stock market under the ticker TARS. Tarsus focuses on developing innovative therapies to address unmet medical needs.
Latest news from Tarsus Pharmaceuticals, Inc.
Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
September 28, 2026
Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care
September 4, 2026
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
August 6, 2026
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
August 6, 2026
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
August 6, 2026
Events
Research Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. company profile
View the public company page for Tarsus Pharmaceuticals, Inc. on 6ix.
Tarsus Pharmaceuticals, Inc. news
Read company news and market updates connected to Tarsus Pharmaceuticals, Inc..
Tarsus Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Tarsus Pharmaceuticals, Inc..